Literature DB >> 2478074

Purification and characterization of macrolide 2'-phosphotransferase from a strain of Escherichia coli that is highly resistant to erythromycin.

K O'Hara1, T Kanda, K Ohmiya, T Ebisu, M Kono.   

Abstract

Macrolide 2'-phosphotransferase [MPH(2')] was purified 90-fold from an erythromycin-resistant strain of Escherichia coli, and its enzymatic properties were investigated. MPH(2') is an inducible intracellular enzyme which showed high levels of activity with 14-member-ring macrolides and extremely low levels with 16-member-ring macrolides. The optimum pH for inactivation of oleandomycin was 8.2, and the optimum temperature of the reaction was 40 degrees C. Enzyme activity was lost by heat treatment at 50 degrees C for 1 min. The isoelectric point and molecular weight of the enzyme were 5.3 and 34,000, respectively. Purine nucleotides, such as GTP, ITP, and ATP, were effective as cofactors in the inactivation of macrolides. Iodine, EDTA, or divalent cations inhibited MPH(2') activity.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2478074      PMCID: PMC172653          DOI: 10.1128/AAC.33.8.1354

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  23 in total

1.  Outer membranes of gram-negative bacteria. XIX. Isolation from Pseudomonas aeruginosa PAO1 and use in reconstitution and definition of the permeability barrier.

Authors:  R E Hancock; H Nikaido
Journal:  J Bacteriol       Date:  1978-10       Impact factor: 3.490

2.  Micro-iodometric assay for penicillinase.

Authors:  R P NOVICK
Journal:  Biochem J       Date:  1962-05       Impact factor: 3.857

3.  Ultrasensitive stain for proteins in polyacrylamide gels shows regional variation in cerebrospinal fluid proteins.

Authors:  C R Merril; D Goldman; S A Sedman; M H Ebert
Journal:  Science       Date:  1981-03-27       Impact factor: 47.728

4.  The purification and properties of penicillin beta-lactamases mediated by transmissible R factors in Escherichia coli.

Authors:  S Yamagishi; K O'Hara; T Sawai; S Mitsuhashi
Journal:  J Biochem       Date:  1969-07       Impact factor: 3.387

5.  Drug resistance of staphylococci. Ability of chloramphenicol related compounds to induce chloramphenicol resistance in Staphylococcus aureus.

Authors:  M Kono; K O'Hara; M Nagawa; S Mitsuhashi
Journal:  Jpn J Microbiol       Date:  1971-05

6.  Enzymatic inactivation of a new aminoglycoside antibiotic, sisomicin by resistant strains of Pseudomonas aeruginosa.

Authors:  K O'Hara; M Kono; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1974-06       Impact factor: 5.191

7.  Mechanisms of streptomycin(SM)-resistance of highly SM-resistant Pseudomonas aeruginosa strains.

Authors:  M Kono; K O'Hara
Journal:  J Antibiot (Tokyo)       Date:  1976-02       Impact factor: 2.649

8.  Microbial degradation of cephalothin by cephalothin-susceptible Escherichia coli.

Authors:  T Nishiura; Y Kawada; Y Shiomi; K O'Hara; M Kono
Journal:  Antimicrob Agents Chemother       Date:  1978-06       Impact factor: 5.191

9.  Nuclear magnetic resonance spectrometric assay of beta-lactamase.

Authors:  M Kono; K O'Hara; Y Shiomi
Journal:  Antimicrob Agents Chemother       Date:  1980-01       Impact factor: 5.191

10.  Reduction of the aerobic Gram negative bacterial flora of the gastro-intestinal tract and prevention of traveller's diarrhea using oral erythromycin.

Authors:  A Andremont; C Tancrede
Journal:  Ann Microbiol (Paris)       Date:  1981 Nov-Dec
View more
  29 in total

Review 1.  Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants.

Authors:  M C Roberts; J Sutcliffe; P Courvalin; L B Jensen; J Rood; H Seppala
Journal:  Antimicrob Agents Chemother       Date:  1999-12       Impact factor: 5.191

Review 2.  Macrolide resistance conferred by base substitutions in 23S rRNA.

Authors:  B Vester; S Douthwaite
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

3.  Decreased azithromycin susceptibility of Neisseria gonorrhoeae due to mtrR mutations.

Authors:  L Zarantonelli; G Borthagaray; E H Lee; W M Shafer
Journal:  Antimicrob Agents Chemother       Date:  1999-10       Impact factor: 5.191

4.  Identification of functional amino acids in the macrolide 2'-phosphotransferase II.

Authors:  K Taniguchi; A Nakamura; K Tsurubuchi; A Ishii; K O'Hara; T Sawai
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

5.  Detection and characterization of a macrolide 2'-phosphotransferase from a Pseudomonas aeruginosa clinical isolate.

Authors:  A Nakamura; I Miyakozawa; K Nakazawa; K O-Hara; T Sawai
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

Review 6.  Intrinsic and unusual resistance to macrolide, lincosamide, and streptogramin antibiotics in bacteria.

Authors:  R Leclercq; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

7.  Application of nanoscale packed capillary liquid chromatography (75 μm id) and capillary zone electrophoresis/electrospray ionization mass spectrometry to the analysis of macrolide antibiotics.

Authors:  C E Parker; J R Perkins; K B Tomer; Y Shida; K O'Hara; M Kono
Journal:  J Am Soc Mass Spectrom       Date:  1992-07       Impact factor: 3.109

Review 8.  Resistance to Macrolide Antibiotics in Public Health Pathogens.

Authors:  Corey Fyfe; Trudy H Grossman; Kathy Kerstein; Joyce Sutcliffe
Journal:  Cold Spring Harb Perspect Med       Date:  2016-10-03       Impact factor: 6.915

9.  Macrolide susceptibility of Mycoplasma hyorhinis isolated from piglets.

Authors:  H Kobayashi; T Morozumi; G Munthali; K Mitani; N Ito; K Yamamoto
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

10.  Clinical strain of Staphylococcus aureus inactivates and causes efflux of macrolides.

Authors:  L Wondrack; M Massa; B V Yang; J Sutcliffe
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.